What's in Dr Sudarshan Rajagopal's pipeline?

Dr Sudarshan Rajagopal has 1 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Dr Sudarshan Rajagopal's portfolio?

Top competitors by shared drug class: AbbVie (prior sponsor, Abbott), Actelion, Bayer, Eli Lilly and Company, Elpen Pharmaceutical Co. Inc..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/dr-sudarshan-rajagopal.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-10 · How we verify

Dr Sudarshan Rajagopal — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Dr Sudarshan Rajagopal pipeline: 0 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Macitentan Tablets	Macitentan Tablets	phase 3	Endothelin receptor antagonist	ETA and ETB receptors	Cardiovascular

Therapeutic area mix

Cardiovascular · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

AbbVie (prior sponsor, Abbott) · 1 shared drug class
Actelion · 1 shared drug class
Bayer · 1 shared drug class
Eli Lilly and Company · 1 shared drug class
Elpen Pharmaceutical Co. Inc. · 1 shared drug class
National Heart, Lung, and Blood Institute (NHLBI) · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Dr Sudarshan Rajagopal:

Cite this brief

Drug Landscape (2026). Dr Sudarshan Rajagopal — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/dr-sudarshan-rajagopal. Accessed 2026-06-10.